ORIC Pharmaceuticals Inc - Short Term Stock Analysis - Analysis | GetAGraph.com
Short-TermMedium-TermLong-TermSignals

ORIC Pharmaceuticals Inc [ORIC]

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Last Updated 22 Jun 2026 @ 08:49 (Exchange is closed)
Last: $0 0.00%
0.00 (↓)
GaG Algo Score™
v1.0
Short
0.00 (↓)
Medium
-1.91 (↓)
Long
-1.81 (↓)
BUY
63.16%
return 3.12%
SELL
21.05%
return 25.38%

Stats

Today's Volume 0
Average Volume 0
Market Cap 878.86M
EPS $-0.340 (Q1 | 2026-05-04)
Next earnings date ($-0.360) 2026-08-11
ATR14 $0.550 (6.48%)
Possible DaySwing $8.22 - $8.77 (6.70%)

Support and Resistance Levels

Line

Pivot Data

Pivot Statistics
Metric Average Median Std Dev
Gain % 29.41% 29.41% 22.87%
Loss % -21.83% -21.83% 7.57%
Duration 16.3d 17d 10.0d
Total Pivots Found 5
Gain/Loss Legs 4 (2 Gain / 2 Loss)
Last Pivot Bottom @ $7.50 on 2026-06-05
Change since Last Pivot $0.99 (13.20%)
Next Pivot Prediction Last: $0.00
Predicted Next Type Top
Predicted Price (Avg) $9.71
Predicted Price (Median) $9.71
Predicted Price Range (~68%) $7.99 - $11.42
Change to Avg Target $9.71 (N/A)
Predicted Date (Avg) 2026-06-21
Predicted Date Range (~68%) 2026-06-11 - 2026-07-01
Basis Based on 2 historical gains (Avg: 29.41%, Median: 29.41%, StdDev: 22.87%) and duration (Avg: 16.2 days, StdDev: 10.0 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Moderate loss for ORIC Pharmaceuticals Inc on Thursday.

ORIC Pharmaceuticals Inc (ORIC) stock price fell steadily on Thursday after the stock fell $-0.140 (-1.62%) from the previous session on above-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 1.91% rise. With 2.77M shares traded, volume yesterday reached $23.53M. This was 1.34M shares more than the prior day. Compared to the 10-day average of 1.55M shares, volume was more than the average.

ORIC Pharmaceuticals Inc signals

There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-10%), medium- (-10%), and long-term (-10%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

ORIC Pharmaceuticals Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $8.50. approximately $0.01000 (0.12%) away. Consolidating near resistance. Breaking above this level could signal further upside where next resistance level will be found at $8.9. On a fall back there will be support at $8.2 The dis das resistance s18.2 -

ORIC Pharmaceuticals Inc Evaluation

  • Short score: 0.00
  • Medium score: -1.91
  • Long score: -1.81